-
公开(公告)号：USD690354S1
公开(公告)日：2013-09-24
申请号：US29408417
申请日：2011-12-12
申请人： Vincent H. Bowman , Jeffrey Herz , Jay K. Sato , Weiye Wu , RunLin Li
设计人： Vincent H. Bowman , Jeffrey Herz , Jay K. Sato , Weiye Wu , RunLin Li
-
公开(公告)号：US20130075349A1
公开(公告)日：2013-03-28
申请号：US13245857
申请日：2011-09-26
IPC分类号： A47B45/00
摘要： An adjustable organizer that includes a plurality of spaced apart vertically oriented dividers and a plurality of selectively stackable platforms extending from the dividers. The platforms increase in height from a foremost platform to a rearmost platform. Adjacent dividers together with a platform extending between the adjacent dividers define a compartment. A connector assembly is operatively associated with one of the dividers and platforms. The connector assembly is configured to allow for independent adjustment of spacing between adjacent dividers to selectively adjust a size of a compartment and to allow a forward platform to slide beneath a platform rearward of the forward platform.
摘要翻译： 一种可调节的组织器，其包括多个间隔开的垂直定向的分隔件和从分隔件延伸的多个可选择性堆叠的平台。 平台的高度从最重要的平台增加到最后台。 相邻的分隔器以及在相邻的分隔器之间延伸的平台限定隔室。 连接器组件可操作地与分隔器和平台中的一个相关联。 连接器组件被配置为允许相邻分隔件之间的间隔的独立调节，以选择性地调节隔间的尺寸并且允许前进平台在平台的下方在前平台的后方滑动。
-
3.发明申请公开(公告)号：US20060205657A1
公开(公告)日：2006-09-14
申请号：US11410406
申请日：2006-04-24
IPC分类号： A61K38/17
CPC分类号： A61K31/18 , A61K9/08 , A61K31/00 , A61K31/352 , A61K31/4045 , A61K31/4164 , A61K31/4168 , A61K31/4174 , A61K31/439 , A61K31/4406 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/465 , A61K31/48 , A61K31/498 , A61K31/506 , A61K31/538 , A61K31/55 , A61K31/675 , A61K38/1793 , A61K45/06 , A61K2300/00
摘要： A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral/dental procedures. The solution preferably includes at least one pharmacological agent that is a class I cytokine soluble receptor, and optionally additional multiple pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents.
摘要翻译： 一种围手术期抑制来自一般外科手术（包括口腔/牙科手术）的伤口的各种疼痛和炎症过程的方法和解决方案。 该溶液优选包含至少一种作为I类细胞因子可溶性受体的药理学试剂，以及任选地在生理载体例如盐水或乳酸林格溶液中稀释浓度的另外多种疼痛和炎症抑制剂。 在外科手术过程中连续冲洗伤口以解决疼痛的预防性作用，同时避免与口服，肌肉内，皮下或静脉内施用较大剂量的药剂相关的不良副作用。
-
4.发明申请Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures 审中-公开环氧合酶抑制剂和钙通道拮抗剂组合物和用于泌尿手术的方法公开(公告)号：US20070248639A1
公开(公告)日：2007-10-25
申请号：US11378618
申请日：2006-03-17
申请人： Gregory Demopulos , Jeffrey Herz
发明人： Gregory Demopulos , Jeffrey Herz
CPC分类号： A61K31/4422 , A61K9/0034 , A61K9/08 , A61K31/00 , A61K31/192 , A61K31/21 , A61K31/40 , A61K31/44 , A61K31/455 , A61L31/16 , A61L2300/402 , A61L2300/41 , A61L2300/432 , A61K2300/00
摘要： Compositions of a cyclooxygenase inhibitor and a calcium channel antagonist in a liquid carrier. The composition may be administered the the urinary tract during urological diagnostic, interventional, surgical and other medical procedures. One disclosed composition comprises ketoprofen and nifedipine in a liquid irrigation carrier, and includes a solubilizing agent, stabilizing agents and a buffering agent.
摘要翻译： 液体载体中环加氧酶抑制剂和钙通道拮抗剂的组成。 组合物可以在泌尿系统诊断，介入，手术和其他医学过程中施用于泌尿道。 一种公开的组合物在液体灌洗载体中包含酮洛芬和硝苯地平，并且包括增溶剂，稳定剂和缓冲剂。
-
5.发明申请公开(公告)号：US20060229588A1
公开(公告)日：2006-10-12
申请号：US11409919
申请日：2006-04-24
CPC分类号： A61K31/18 , A61K9/08 , A61K31/00 , A61K31/352 , A61K31/4045 , A61K31/4164 , A61K31/4168 , A61K31/4174 , A61K31/439 , A61K31/4406 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/465 , A61K31/48 , A61K31/498 , A61K31/506 , A61K31/538 , A61K31/55 , A61K31/675 , A61K38/1793 , A61K45/06 , A61K2300/00
摘要： A method and solution for perioperatively inhibiting a variety of pain and inflammation processes at wounds from general surgical procedures including oral/dental procedures. The solution preferably includes at least one pharmacological agent that is a soluble receptor tyrosine kinase, and optionally additional multiple pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents.
摘要翻译： 一种围手术期抑制来自一般外科手术（包括口腔/牙科手术）的伤口的各种疼痛和炎症过程的方法和解决方案。 该溶液优选包含至少一种作为可溶性受体酪氨酸激酶的药理学试剂，以及任选地在生理载体例如盐水或乳酸林格氏溶液中稀释浓度的另外多种疼痛和炎症抑制剂。 在外科手术过程中连续冲洗伤口以解决疼痛的预防性作用，同时避免与口服，肌肉内，皮下或静脉内施用较大剂量的药剂相关的不良副作用。
-
公开(公告)号：USD709552S1
公开(公告)日：2014-07-22
申请号：US29408728
申请日：2011-12-15
申请人： Vincent H. Bowman , Jeffrey Herz , Jay K. Sato
设计人： Vincent H. Bowman , Jeffrey Herz , Jay K. Sato
-
公开(公告)号：USD682933S1
公开(公告)日：2013-05-21
申请号：US29408499
申请日：2011-12-13
申请人： Vincent H. Bowman , Jeffrey Herz , RunLin Li
设计人： Vincent H. Bowman , Jeffrey Herz , RunLin Li
-
公开(公告)号：US20060210552A1
公开(公告)日：2006-09-21
申请号：US11436941
申请日：2006-05-18
申请人： Gregory Demopulos , Pamela Palmer , Jeffrey Herz
发明人： Gregory Demopulos , Pamela Palmer , Jeffrey Herz
IPC分类号： A61K39/395 , A61K38/48 , A61K38/18 , A61K9/14
CPC分类号： A61K9/0019 , A61K9/08 , A61K31/352 , A61K31/4164 , A61K31/4168 , A61K31/4174 , A61K31/439 , A61K31/4406 , A61K31/4427 , A61K31/4439 , A61K31/444 , A61K31/498 , A61K31/505 , A61K31/538 , A61K38/1793 , A61K38/1825 , A61K38/1841 , A61K38/1875 , A61K38/20 , A61K38/2026 , A61K38/2066 , A61K38/2086 , A61K38/30 , A61K39/395 , A61K45/06 , A61K47/6849 , A61K47/6929 , A61K47/6935 , A61K47/6937 , A61K2300/00
摘要： Methods and compositions for inhibiting articular cartilage degradation. The compositions preferably include multiple chondroprotective agents, including at least one agent that promotes cartilage anabolic activity and at least one agent that inhibits cartilage catabolism. The compositions may also include one or more pain and inflammation inhibitory agents. The compositions may be administered systemically, such as to treat patients at risk of cartilage degradation at multiple joints, and suitably may be formulated in a carrier or delivery vehicle that is targeted to the joints. Alternatively the compositions may be injected or infused directly into the joint.
-
公开(公告)号：USD690353S1
公开(公告)日：2013-09-24
申请号：US29402729
申请日：2011-09-26
申请人： Vincent H. Bowman , Jeffrey Herz , Jay K. Sato , Weiye Wu
设计人： Vincent H. Bowman , Jeffrey Herz , Jay K. Sato , Weiye Wu
-
公开(公告)号：USD688309S1
公开(公告)日：2013-08-20
申请号：US29402733
申请日：2011-09-26
-
-
-
-
-
-
-
-
-
搜索结果
16 条记录 (耗时 0.019 秒)
